The Journal of mHealth Vol 1 Issue 1 (Feb 2014) | Page 27

with Aventyn’s Vitalbeat chronic
disease management ecosystem,
this web-based solution will enable hospitals, physician offices,
university medical centres, home
care providers, hospices and clinical researchers to remotely monitor patient physical activity and
capture relevant changes in activities of daily living. The patented
PAMSys technology is based on
over 10 years of research supported in part by the National
Institutes of Health. PAMSys is
a lightweight, wearable motion
sensor that uses advanced signal
processing algorithms and novel
biomechanical models of human
motion to monitor body position,
evaluate walking patterns, automatically detect falls, and assess
sit-to-stand and stand-to-sit postural transitions.
Vitalbeat™ is a simple, cost effective remote patient monitoring and integrated chronic disease
management system for managing long term conditions. With
Vitalbeat and advanced telehealth
sensors like PAMSys, clinicians
remotely monitor patient vital
signs and activity levels securely
using smartphones and tablet
computers, and design long term
disease management programs
for co-morbidities associated with
heart failure, diabetes, obesity, and
many other conditions. Patients

manage diet, physical activity, and
medication compliance by configurable alerts and reminders based
on personalised thresholds, goals
and clinical requirements. Patient
electronic health record data integrates with Vitalbeat along with
social networking sites like Twitter and Facebook to provide care
continuity, group sharing and networking with clinicians, family
and like-minded friends.

ton, D.C., Eric Dishman, Intel Fellow and general manager of Intel’s
Health & Life Sciences Group,
reiterated Intel’s belief that next
generation technology for continuous monitoring of patient vital signs, such as ViSi® Mobile by
Sotera® Wireless shown live during the keynote, could transform
the delivery of care and benefit
health outcomes, patient satisfaction, and healthcare costs.

PAMSys™ with Vitalbeat™ is
selectively available for clinical
research and commercial deployment by healthcare providers and
payers. The two companies plan
to provide remote patient monitoring solutions and subscription
services for a variety of disease
conditions to be billed under existing CPT codes for ambulatory
electrocardiographic monitoring,
education and patient self-management, and fall risk assessment,
as well as new CPT codes based
on clinical outcomes from ongoing and future clinical trials.

“A great example of mobile technology that holds promise to improve patient safety and the whole
experience of being a high-risk
patient is continuous monitoring
of vital signs in the hospital,” said
Dishman. “Rather than inconvenient manual spot checks that
yield intermittent data, this mobile technology makes it possible
for the first time to monitor all
vital signs continuously through a
small, wearable device that transmits data wirelessly.”

VISI MOBILE
PRESENTED DURING
ERIC DISHMAN’S
MHEALTH SUMMIT
KEYNOTE ADDRESS
Following his keynote address at
the mHealth Summit in Washing-

A finalist for CONNECT’s 2013
“Most Innovative Product”
Award, the ViSi Mobile System
packs powerful patient monitoring capabilities into a 4 ounce
wrist-worn device ensuring clinicians anytime, anywhere access to
accurate and trended vital sign information. With the recent addition of continuous, cuffless nonContinued on page 26

25
The Journal of mHealth